This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Daniel A. Hoffman, PhD; William M. McConahey, MD; Louise A. Brinton, PhD; Joseph F. Fraumeni, Jr, MD

JAMA. 1984;251(5):616-619.

Abstract
The risk of breast cancer associated with thyroid supplementation for iatrogenic hypothyroidism was investigated in women treated for hyperthyroidism at the Mayo Clinic, Rochester, Minn. One or more years after the diagnosis of hypothyroidism, there were 47 cases of breast cancer observed among 1,665 women compared with 52.9 cases expected, a ratio of observed to expected cases (standardized incidence ratio [SIR]) of 0.9. There was also no breast cancer excess among women who remained euthyroid (SIR=1.0). Breast cancer risks were not influenced by various factors associated with the management of hyperthyroidism or subsequent hypothyroidism. No increased risk was observed in hypothyroid women categorized by breast cancer risk factors except for women who reported a previous breast biopsy, an excess also observed among euthyroid patients. The results of this study indicate that use of thyroid supplements does not increase the risk of breast cancer developing.

(JAMA 1984;251:616-619)

Author Affiliations
From the Environmental Epidemiology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (Drs Hoffman, Brinton, and Fraumeni); and the Department of Internal Medicine, Division of Endocrinology/Metabolism and Internal Medicine, Mayo Clinic, Rochester, Minn (Dr McConahey).

Footnotes
Reprint requests to National Cancer Institute, Environmental Epidemiology Branch, 3C16 Landow Bldg, Bethesda, MD 20205 (Dr Hoffman).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Correspondence re: Simon et al., Do Thyroid Disorders Increase the Risk of Breast Cancer? 11: 1574-1578, 2002
Altieri et al.
Cancer Epidemiol. Biomarkers Prev. 2003;12:684-686.
FULL TEXT  

The Association of Benign and Malignant Ovarian Adenofibromas with Breast Cancer and Thyroid Disorders
Silva et al.
INT J SURG PATHOL 2002;10:33-39.
ABSTRACT  

Is Long-term Levothyroxine Therapy Safe?
BURMAN
Arch Intern Med 1990;150:2010-2013.
ABSTRACT  

Morbidity, Mortality, and Quality of Life for Patients Treated With Levothyroxine
Petersen et al.
Arch Intern Med 1990;150:2077-2081.
ABSTRACT